Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Wednesday, 28 October 2020
Ampco
Latest News
AZ losing patience with system
Public call for faster approvals, more incentives
Novartis, MA in new consortium
Regenerative Medicine Catalyst Body launched
Oz pharma bosses tell all
Four leaders unveil their Covid learnings
Bayer resets for future focus
Latest pharma to go through transformation
MSAC ticks kid cancer drug
Recommended for rare disease - with a price cut
Top of the Hill
How much to save the kid?
We paid a high price for our elderly so what about children
Most Popular
Pharma job loss fears soar
Half pharma workers concerned about Covid sackings
Aust pharma salaries flatline
One in three got nothing, others very little
Novartis' costly Nov PBS win
Mayzent listed for new MS patients after price cut
No instant vax cure for Aust
'Normal' won't be back before 2022: Neville Power
Govt PBS record exposed
New listing analysis challenges 'one a day' PBS claim
Earlier
Older Aussies miss Covid vaxes
Murphy says first vaccines likely to exclude over 65s
PBS budgets savings, not spend
'But we're good for it' Health tells Senate Estimates
Gene eye drug stuck on price
MSAC delays to bargain down million dollar drug
Pfizer pill shorts continue
Aussie pharma to make alternative contraceptives
Aust looking at lots of vaxes
In active discussions with multiple Covid vax makers
Special Report
Aust Covid Vaccine Tracker
UPDATES: Aust to import 3.8m vax doses; FDA approves Veklury
Approvals Action
Novartis' triplet inhaler ticked
First-in-class maintenance treatment of asthma
Top of the Hill
Patients a PBAC headache
Failure to close expectation gap is a causing problem
Latest Jobs

Pharma in Focus  Jobs
X
Pharma Guide
SEARCH NOW
Ascott
© 2003 - 2020 Lush Media | Privacy Statement | Subscribe to Pharma in Focus | Design: Jolly Good Design